LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2024/566 of 14 February 2024 amending Annex VIII to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain zones of Germany and Spain as regards infection with bluetongue virus (serotypes 1-24) and the approval of the extension of an eradication programme for infection with that virus

Commission Implementing Regulation (EU) 2024/566 of 14 February 2024 amending Annex VIII to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain zones of Germany and Spain as regards infection with bluetongue virus (serotypes 1-24) and the approval of the extension of an eradication programme for infection with that virus

Implementing Regulation (EU) 2024/566 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Annex VIII to Implementing Regulation (EU) 2021/620 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Annex VIII to Implementing Regulation (EU) 2021/620 is amended as follows: (1) Part I is amended as follows: (a) the entry for Germany is replaced by the following: Member State Territory ‘Germany Whole territory except Bundesland Bremen, Niedersachsen, Nordrhein-Westfalen’ (b) the entry for Spain is replaced by the following: Member State Territory ‘Spain Comunidad Autónoma de Aragón Comunidad Autónoma de Canarias Comunidad Autónoma de Castilla-La Mancha: Province of Guadalajara Comunidad Autónoma de Castilla y León, except the following areas: Province of Ávila Province of Salamanca Cantalejo, Carbonero El Mayor, Santa María la Real de Nieva, Segovia, Villacastín in the Province of Segovia Alcañices, Bermillo de Sayago, Puebla de Sanabria in the Province of Zamora Comunidad Autónoma de Cataluña Comunidad Autónoma de La Rioja Comunidad Autónoma de las Islas Baleares Comunidad Autónoma de Navarra Comunidad Autónoma del País Vasco Comunidad Autónoma de Valencia’ (2) Part II is replaced by the following: ‘PART II Member States or zones thereof with an approved eradication programme for infection with BTV Member State Territory Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689 Spain Comunidad Autónoma de Andalucía Comunidad Autónoma de Castilla-La Mancha, except the Province of Guadalajara Comunidad Autónoma de Asturias Comunidad Autónoma de Cantabria Comunidad Autónoma de Castilla y León: Province of Ávila Province of Salamanca Province of Segovia, the following districts: Cantalejo, Carbonero El Mayor, Santa María la Real de Nieva, Segovia, Villacastín Province of Zamora, the following districts: Alcañices, Bermillo de Sayago, Puebla de Sanabria Comunidad Autónoma de Extremadura Comunidad Autónoma de Galicia Comunidad Autónoma de Madrid Comunidad Autónoma de Murcia 21 February 2022’

Other acts of the same type
Commission Regulation (EU) 2019/225 of 6 February 2019 amending Regulation (EC) No 748/2009 as regards the aircraft operators for which the United Kingdom is specified as administering Member State (Text with EEA relevance.)Commission Regulation (EU) 2019/226 of 6 February 2019 amending Regulation (EC) No 748/2009 on the list of aircraft operators which performed an aviation activity listed in Annex I to Directive 2003/87/EC on or after 1 January 2006 specifying the administering Member State for each aircraft operator (Text with EEA relevance.)Commission Regulation (EU) 2019/319 of 6 February 2019 amending Annex IX to Regulation (EC) No 999/2001 of the European Parliament and of the Council and Annex XV to Commission Regulation (EU) No 142/2011 as regards health certification at import into the Union concerning transmissible spongiform encephalopathies (Text with EEA relevance.)Commission Delegated Regulation (EU) 2019/885 of 5 February 2019 supplementing Regulation (EU) 2017/2402 of the European Parliament and of the Council with regard to regulatory technical standards specifying information to be provided to a competent authority in an application for authorisation of a third party assessing STS compliance (Text with EEA relevance.)Commission Delegated Regulation (EU) 2019/820 of 4 February 2019 supplementing Regulation (EU) No 345/2013 of the European Parliament and of the Council with regard to conflicts of interest in the area of European venture capital funds (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/162 of 1 February 2019 amending Council Regulation (EC) No 1210/2003 concerning certain specific restrictions on economic and financial relations with IraqCommission Implementing Regulation (EU) 2019/218 of 1 February 2019 approving an amendment to the specification for a Protected Designation of Origin or a Protected Geographical Indication (‘Vinos de Madrid’ (PDO))Commission Delegated Regulation (EU) 2019/819 of 1 February 2019 supplementing Regulation (EU) No 346/2013 of the European Parliament and of the Council with regard to conflicts of interest, social impact measurement and information to investors in the area of European social entrepreneurship funds (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/158 of 31 January 2019 renewing the approval of the active substance methoxyfenozide, as a candidate for substitution, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/159 of 31 January 2019 imposing definitive safeguard measures against imports of certain steel productsCommission Implementing Regulation (EU) 2019/168 of 31 January 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis (Cohn 1872) Strain QST 713, Bacillus thuringiensis subsp. Aizawai, Bacillus thuringiensis subsp. israeliensis, Bacillus thuringiensis subsp. kurstaki, Beauveria bassiana, benfluralin, clodinafop, clopyralid, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, epoxiconazole, fenpyroximate, fluazinam, flutolanil, fosetyl, Lecanicillium muscarium, mepanipyrim, mepiquat, Metarhizium anisopliae var. Anisopliae, metconazole, metrafenone, Phlebiopsis gigantea, pirimicarb, Pseudomonas chlororaphis strain: MA 342, pyrimethanil, Pythium oligandrum, rimsulfuron, spinosad, Streptomyces K61, thiacloprid, tolclofos-methyl, Trichoderma asperellum, Trichoderma atroviride, Trichoderma gamsii, Trichoderma harzianum, triclopyr, trinexapac, triticonazole, Verticillium albo-atrum and ziram (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/219 of 31 January 2019 entering a name in the register of protected designations of origin and protected geographical indications (‘Bulot de la Baie de Granville’ (PGI))

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next